Gynecology/Obstetrics CME

Credits: 1.00 CME / MOC
Medical Learning Institute, Inc.
Making the Most of the New Era of Immuno-Oncology in TNBC: Essential Guidance for Surgeons on How to Maximize the Potential of Immunotherapies and Combinations in Advanced and Early-Stage Breast Cancer
George Plitas, MD
September 21, 2020
Credits: 1.25 CME / MOC / CNE
Medical Learning Institute, Inc.
The Era of Immuno-Oncology in TNBC: Navigating Evidence in Early-Stage and Advanced Disease, Practicalities of Integration, and Implications for Breast Surgeons
George Plitas, MD
August 28, 2020
Credits: 1.50 CME / MOC
Medical Learning Institute, Inc.
Moving in Leaps and Bounds Toward Expanded Precision Treatment of HER2- or HER3-Driven Breast, Gastrointestinal, Lung, and Other Cancers: Current Challenges, Opportunities for Improvement, and Practical Considerations
Erika Hamilton, MD
August 6, 2020
Credits: 1.00 CNE
Medical Learning Institute, Inc.
Rethinking Patient Care in Endometrial and Cervical Cancer: How Nurses Can Lead the Targeted and Immunotherapeutic Revolution
Kimberly Halla, MSN, FNP-C
August 5, 2020
Credits: 1.00 CME
Medical Learning Institute, Inc.
Current and Emerging Therapies for Endometriosis and Uterine Fibroids: What Do You Need to Know?
Georgine Lamvu, MD, MPH
August 3, 2020
Credits: 1.00 CME / MOC
Medical Learning Institute, Inc.
Evidence Informing Practice: Changing Standards of Care for Use of CDK4 and 6 Inhibitors in the Treatment of Breast Cancer
Joyce O’Shaughnessy, MD
July 23, 2020
Credits: 1.00 CME / MOC
Medical Learning Institute, Inc.
Harnessing the Immune System in the Treatment of Triple-Negative Breast Cancer to Maximize Benefits to Patients: State of the Science, Key Trials, Implications for Practice, and Patient-Centric Clinical Decision-Making
Heather L. McArthur, MD, MPH
July 22, 2020
Credits: 1.00 CME / MOC
Medical Learning Institute, Inc.
Optimizing Precision Medicine in Ovarian Cancer: Expert Insights on Clinical Implications of PARP Inhibitor Therapy and Companion Diagnostics
Bradley J. Monk, MD, FACS, FACOG
July 21, 2020
Credits: 1.00 CME / MOC
Medical Learning Institute, Inc.
Practical Perspectives on Rapid Change in Endometrial and Cervical Cancer Management: Exploring Innovative Therapy in Gynecologic Malignancies
Linda R. Duska, MD, MPH
July 17, 2020
Credits: 0.50 CME / MOC
Medical Learning Institute, Inc.
Chair's Take on Harnessing the Immune System in the Treatment of TNBC and Beyond: Where Are We Now and Where Are We Going Next?
Heather L. McArthur, MD, MPH
July 9, 2020
Credits: 0.50 CME / MOC
Medical Learning Institute, Inc.
Chair's Take: Latest and Emerging Evidence of PARP Inhibitors in Ovarian Cancer Management
Bradley J. Monk, MD, FACS, FACOG
June 18, 2020
Credits: 0.50 CME / MOC
Medical Learning Institute, Inc.
Chair’s Take on Advances in Gynecologic Cancer Care: Exploring New Advances and Innovative Therapies in Endometrial and Cervical Cancers
Linda R. Duska, MD, MPH
June 16, 2020
Credits: 0.50 CME / MOC
Medical Learning Institute, Inc.
Expert Views on the Evolving Role of PARP Inhibitors in the Treatment of Ovarian Cancer
Bradley J. Monk, MD, FACS, FACOG
April 30, 2020
Credits: 1.50 CME / MOC / CNE
Medical Learning Institute, Inc.
On the Cusp of the Era of Immuno-Oncology in Triple-Negative Breast Cancer: Rational Strategies to Make the Most of Immunotherapies and Other Effective Treatment Modalities Throughout the Disease Continuum
Peter Schmid, FRCP, MD, PhD
December 30, 2019
Credits: 1.00 CME / CNE
Penn State College of Medicine
Advances in Precision Care in Solid Tumor Oncology: Defining the Role of PARP Inhibitors
Robert Coleman, MD
November 8, 2019